Description
Research overview
Retatrutide is an investigational multi-receptor peptide studied for agonism across GLP-1, GIP, and glucagon receptors. The 5mg INPEP listing is positioned for qualified research and analytical workflows, not consumer use.
Research applications
- Triple-receptor co-agonism studies involving GLP-1R, GIPR, and GCGR signaling.
- Comparative incretin and glucagon-pathway research alongside single- and dual-agonist peptides.
- Receptor activation, cAMP signaling, peptide stability, and assay-development models.
Catalog benefits
- 5mg lyophilized format with corrected product naming and clear amount display.
- Professional page copy that avoids weight-loss, dosing, and disease-treatment claims.
- Useful catalog reference for researchers comparing next-generation incretin-pathway compounds.
Research-use notice: This product is not intended to diagnose, treat, cure, or prevent disease and is not for human or animal consumption.
Reviews
There are no reviews yet.